Charles River Beats Q3, Lifts 2026 Guidance as Non-GAAP EPS Jumps 27%
CRL has more than doubled off its 52-week low of $146.195.
Summary
Charles River beat third-quarter expectations and raised its 2026 revenue and EPS guidance, now seeing adjusted EPS of $11.35 to $11.65, up from its prior $11.15 to $11.45, and revenue down 1.5% to 2%, narrowed from a prior down 2.5% to 3.5%. It now expects 2026 organic revenue up at least 1.5%, versus a prior flat to up 1%. Non-GAAP diluted EPS came in at $3.09, up 27.2% year over year, helped partly by a lower tax rate, while net income was $333.1 million. Reported revenue fell 2.2% to $982.7 million, but organic revenue grew 4.7% — the decline was driven primarily by May 2026 divestitures. GAAP EPS of $6.86 includes a $5.06 tax benefit from a reserve reversal, so it overstates recurring performance. This follows the August Q2 beat that triggered a wave of analyst upgrades and the September Investor Day that reaffirmed 2026 guidance at the upper end of ranges; the stock is trading near its 52-week high.
Updates
· SEC 8-K — Charles River's raised 2026 non-GAAP EPS guidance is $11.35-$11.55, with GAAP EPS $8.15-$8.35 including a $5.03 reversal of acquired tax reserves.
At the time of this announcement, CRL was trading at $362.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $16.8B. The 52-week trading range was $146.20 to $379.63. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.